Projects per year
Fingerprint
Dive into the research topics where Shaji K Kumar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Project 2 - IMiD Resistance in Patients and Humanized Mice with Multiple Myeloma
Meurice, N., Kumar, S. K. & Bergsagel, L.
9/30/17 → 8/31/22
Project: Research project
-
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
Mailankody, S., Matous, J. V., Chhabra, S., Liedtke, M., Sidana, S., Oluwole, O. O., Malik, S., Nath, R., Anwer, F., Cruz, J. C., Htut, M., Karski, E. E., Lovelace, W., Dillon, M., Butz, E., Ying, W., Balakumaran, A. & Kumar, S. K., Feb 2023, In: Nature Medicine. 29, 2, p. 422-429 8 p.Research output: Contribution to journal › Article › peer-review
-
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)
Visram, A., Hayman, S. R., Dispenzieri, A., Kapoor, P., Lacy, M. Q., Gertz, M. A., Buadi, F. K., Dingli, D., Warsame, R., Kourelis, T., Cook, J., Binder, M., Gonsalves, W., Muchtar, E., Leung, N., Roy, V., Rajkumar, S. V. & Kumar, S., Aug 2023, In: American journal of hematology. 98, 8, p. 1277-1285 9 p.Research output: Contribution to journal › Article › peer-review
-
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk
Dicanio, M., Giaccherini, M., Clay-Gilmour, A., Macauda, A., Sainz, J., Machiela, M. J., Rybicka-Ramos, M., Norman, A. D., Tyczyńska, A., Chanock, S. J., Barington, T., Kumar, S. K., Bhatti, P., Cozen, W., Brown, E. E., Suska, A., Haastrup, E. K., Orlowski, R. Z., Dudziński, M., Garcia-Sanz, R., & 42 others, Jan 15 2023, In: International Journal of Cancer. 152, 2, p. 239-248 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma
Chng, W. J., Lonial, S., Morgan, G. J., Iida, S., Moreau, P., Kumar, S. K., Twumasi-Ankrah, P., Villarreal, M., Dash, A. B., Vorog, A., Zhang, X., Suryanarayan, K., Labotka, R., Dimopoulos, M. A. & Rajkumar, S. V., Dec 2023, In: Blood cancer journal. 13, 1, 14.Research output: Contribution to journal › Article › peer-review
Open Access -
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance
Ryu, A. J., Kumar, S., Dispenzieri, A., Kyle, R. A., Rajkumar, S. V. & Kingsley, T. C., Dec 2023, In: Blood cancer journal. 13, 1, 28.Research output: Contribution to journal › Article › peer-review
Open Access